Side, Lucy E <br/><br/>
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.  [electronic resource] 

 -  Genes, chromosomes & cancer  Mar 2004 
 - 217-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1045-2257 
<br/><br/><label>Standard No.: </label>10.1002/gcc.10320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Child, Preschool<br/>Chromosome Aberrations<br/>Chromosomes, Human, Pair 5--genetics<br/>Chromosomes, Human, Pair 7--genetics<br/>Female<br/>Humans<br/>Leukemia, Myeloid--genetics<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Tumor Suppressor Protein p53--genetics<br/>fms-Like Tyrosine Kinase 3